# Investigation to Identify Predictors of Response to a Treatment With Montelukast

> **NCT00721240** · PHASE4 · COMPLETED · sponsor: **Marien Hospital Wesel** · enrollment: 50 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** montelukast

## Key facts

- **NCT ID:** NCT00721240
- **Lead sponsor:** Marien Hospital Wesel
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2008-12
- **Final completion:** 2009-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2010-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00721240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00721240, "Investigation to Identify Predictors of Response to a Treatment With Montelukast". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00721240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*